Vuong Trieu - 06 Dec 2022 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role: CHAIRMAN AND CEO, Director, 10%+ Owner
Signature: /s/ Trieu, Vuong
Issuer symbol: OTLC
Transactions as of: 06 Dec 2022
Net transactions value: +$6,000
Form type: 4
Filing time: 07 Dec 2022, 07:00:32 UTC
Previous filing: 25 Nov 2022
Next filing: 02 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership
transaction	OTLC	Common Stock	Purchase	$6,000	+120,000	+0.13%	$0.0500	90,558,021	06 Dec 2022	Direct
holding	OTLC	Common Stock						16,780,384	06 Dec 2022	By Autotelic, Inc.
holding	OTLC	Common Stock						6,872,529	06 Dec 2022	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Dr. Trieu purchased 120,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity on December 6, 2022 from the open market at a price of $0.05.